Immunoprotein Diagnostic Testing Market stares at the bright future in the light of increasing prevalence of chronic diseases accompanied by COVID-19 crisis

Overview:

Immunoproteins are blood proteins that play an important role in the functioning of the immune system. These proteins show an abnormal increase in the blood concentrations, as they have an immunological activity against pathogenic substances/organisms, which serves as a potential indicator in prognosis during the diseased state. Moreover, immunoproteins form an integrated body system in cells, organs, and/or tissues that help neutralize the harmful effects of antigens. These proteins also help diagnose many diseases such as cardiovascular diseases, infectious diseases, and oncological conditions.

Get Sample Report With Latest Covid19 Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/502

Drivers:

Increasing prevalence of chronic diseases around the world is expected to propel growth of the global immunoprotein diagnostic testing market over the forecast period. For instance, as per the World Health Organization (WHO), diabetes was responsible for around 1.6 million deaths, while lung cancer for around 1.6 million deaths in 2012. Thus, there is an increase in demand for early diagnosis, as well as suitable diagnostic testing (such as immunoprotein diagnostic testing), to prevent high mortality rates. Moreover, the prevalence of diabetes has increased from 108 million in 1980 to 422 million in 2014.

Furthermore, prevalence of non-communicable diseases and the growing geriatric population across the globe is expected to drive growth of the global immunoprotein diagnostic testing market. For instance, according to WHO, in 2017, non- communicable diseases, such as cancer, diabetes, chronic lung diseases, and cardiovascular diseases, account for around 39.5 million deaths around the world.

Rise in the incidence of infectious diseases, well- established healthcare systems, and increase in awareness among population towards early diagnosis are some major factors expected to aid in the growth of the global immunoprotein diagnostic testing market.

Regional Insights:

Among regions, North America and Asia Pacific are expected to witness robust growth in the global immunoprotein diagnostic testing market due to availability of technologically advanced devices, well-established healthcare infrastructures, improvement in the healthcare facilities, increase in healthcare and diagnostic services demand, and increase in per capita income.

Reasons to Purchase this Report

• Current and future of global Immunoprotein Diagnostic Testing Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations

𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!!!!!!!

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏

Purchase This Premium Report With Discounted Rate @ https://www.coherentmarketinsights.com/insight/buy-now/502

Market Taxonomy:

By Technology:

• Radioimmunoassay
• Immunoturbidity Assay
• Chemiluminescence assay
• Immunoprotein Electrophoresis
• Enzyme- based Immunoassay
• Immunofluorescence Assay

By Test Type:

• C- reactive Protein Diagnostic Test
• Complement System Protein Diagnostic Test
• Prealbumin Diagnostic Test
• Hepatoglobin Diagnostic Test
• Immunoglobulin Diagnostic Test
• Free Light Chain Diagnostic Test

By Application:

• Autoimmune Testing
• Infectious Disease Testing
• Allergy Testing
• Endocrine Testing
• Oncology Testing
• Toxicology Testing

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Competitive Landscape:

Key players operating in the global immunoprotein diagnostic testing market are DiaSorin SPA, Thermo Fisher Scientific, Randox Laboratories, Roche, Fujirebio Diagnostics, Inc., Enzo Life Sciences, Inc., BioMerieux, AdnaGen, Agilent Technologies, Abcam PLC, and Abbott Laboratories, Inc., among others.

Key Developments:

In June 2019, Eurobio Scientific entered into exclusive negotiations with Vivo Medical Group to acquire Personal Diagnostics Ltd. and Pathway Diagnostics Ltd.

In April 2019, Meridian Bioscience announced that the company has entered into a definitive agreement to acquire the business of GenePOC Inc.

In June 2016, Beckman Coulter, Inc. and Ortho Clinical Diagnostics announced a strategic relationship regarding sales of Ortho’s VITROS 3600 Immunodiagnostic System and infectious disease menu in the United States.

In April 2016, DiaSorin announced the launch of a new serological assay that can be used with the LIAISON Analyzer.

In MAY 2016, DiaSorin announced the completion of the transaction to acquire the Focus Diagnostics’ immunodiagnostic and molecular diagnostic business from Quest Diagnostics.

Request Here For PDF Brochure With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/502

Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Immunoprotein Diagnostic Testing Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Immunoprotein Diagnostic Testing Industry Impact

Chapter 2 Global Immunoprotein Diagnostic Testing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Immunoprotein Diagnostic Testing (Volume and Value) by Type
2.3 Global Immunoprotein Diagnostic Testing (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Immunoprotein Diagnostic Testing Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Immunoprotein Diagnostic Testing Market Analysis
Chapter 6 East Asia Immunoprotein Diagnostic Testing Market Analysis
Chapter 7 Europe Immunoprotein Diagnostic Testing Market Analysis
Chapter 8 South Asia Immunoprotein Diagnostic Testing Market Analysis
Chapter 9 Southeast Asia Immunoprotein Diagnostic Testing Market Analysis
Chapter 10 Middle East Immunoprotein Diagnostic Testing Market Analysis
Chapter 11 Africa Immunoprotein Diagnostic Testing Market Analysis
Chapter 12 Oceania Immunoprotein Diagnostic Testing Market Analysis
Chapter 13 South America Immunoprotein Diagnostic Testing Market Analysis
Chapter 14 Company Profiles and Key Figures in Immunoprotein Diagnostic Testing Business
Chapter 15 Global Immunoprotein Diagnostic Testing Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology